Quantinno Capital Management LP Bristol Myers Squibb CO Transaction History
Quantinno Capital Management LP
- $9.91 Billion
- Q4 2024
A detailed history of Quantinno Capital Management LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Quantinno Capital Management LP holds 252,908 shares of BMY stock, worth $14.5 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
252,908
Previous 198,804
27.21%
Holding current value
$14.5 Million
Previous $10.3 Million
39.04%
% of portfolio
0.14%
Previous 0.14%
Shares
15 transactions
Others Institutions Holding BMY
# of Institutions
2,753Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.9 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.1 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.51 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.46 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.46 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $122B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...